4//SEC Filing
Diaz-Mitoma Francisco 4
Accession 0001493152-20-001079
CIK 0000764195other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:23 PM ET
Size
6.5 KB
Accession
0001493152-20-001079
Insider Transaction Report
Form 4
Diaz-Mitoma Francisco
Chief Medical Officer
Transactions
- Award
Option (Right to Buy Common Shares)
2020-01-22+350,000→ 350,000 totalExercise: $1.66Exp: 2030-01-22→ Common Shares (350,000 underlying)
Footnotes (3)
- [F1]Exercise price represents the volume weighted average closing price of the Issuer's common shares on the Nasdaq Capital Market for Grant Date (as defined below) and the four (4) trading days preceding the Grant Date.
- [F2]The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 22, 2020 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 22, 2020 (the "Option Agreement"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date.
- [F3]The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.
Documents
Issuer
VBI Vaccines Inc/BC
CIK 0000764195
Entity typeother
Related Parties
1- filerCIK 0001701865
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:23 PM ET
- Size
- 6.5 KB